Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
84 hedge funds and large institutions have $130M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
148% more call options, than puts
Call options by funds: $4.25M | Put options by funds: $1.71M
Top Buyers
Top Sellers
FRTX Hedge Fund Activity: Q2 2013 in Review
84 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2013, worth a combined $130M.
Buyers outnumbered sellers: 84 funds opened new FRTX positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.
- 84 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $130M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2013.
- 84 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +84 holders.
Based on aggregated 13F filings for Q2 2013.